Yang Yin Fu Zheng Jie Du Therapy in Recurrence of Hepatocellular Carcinoma Less Than 3 cm in Diameter

Yang Yin Fu Zheng Jie Du Therapy in Recurrence of Hepatocellular Carcinoma Less Than 3 cm in Diameter

Clinical research of Yang Yin Fu Zheng Jie Du therapy in recurrence of Hepatocellular Carcinoma less than 3 cm in diameter.The purpose of this study is to observe the efficacy of routine medical care combined with Yang Yin Fu Zheng Jie Du therapy in 1 year recurrence for patients belong to Hepatocellular Carcinoma less than 3 cm in diameter.

Inclusion Criteria:

• Meet the criteria of hepatocellular carcinoma
• Ages Eligible for Study: ≤75 years old;
• The size of the main nodule and multi-centricity (single lesion, three nodules ≤3 cm)
• After transarterial chemoembolisation (TACE) or radiofrequency ablation (RFA)
• Surgery cannot be allowed;
• Informed consent from the patient.

Exclusion Criteria:

• Serious problem of heart, lung, or kidney with severe dysfunction;
• Pregnant or child breast feeding women;
• Mental or cognitive disorders;
• Participating in other drug trials;
• Who are allergic to the study drug.